DSGN Operating Cash Flow (Statement)
Design Therapeutics Inc · Operating Cash Flow (Statement)
DSGN Operating Cash Flow (Statement)
Latest reported-$15.52Mperiod ending
DSGN Quarterly Cash from Operations (-$2.66M → -$15.52M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
DSGN operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -15,524,000 | |
| -16,431,000 | |
| -11,966,000 | |
| -11,162,000 | |
| -14,441,000 | |
| -16,789,000 | |
| -9,860,000 | |
| -9,546,000 | |
| -11,260,000 | |
| -12,439,000 | |
| -12,798,000 | |
| -14,534,000 | |
| -13,804,000 | |
| -17,424,000 | |
| -15,091,000 | |
| -13,899,000 | |
| -10,500,000 | |
| -11,827,000 | |
| -9,227,000 | |
| -8,164,000 | |
| -8,289,000 | |
| -3,697,000 | |
| -2,844,000 | |
| -1,859,000 | |
| -1,307,000 | |
| -2,659,000 |